Genentech shared today on LinkedIn:
“We are excited to share that Ashley Magargee has been appointed our Chief Executive Officer effective January 1, 2024.
Most recently Head of Commercial Portfolio, Ashley is a 20-year Roche and Genentech veteran with a deep commitment to our people, the patients we serve, and the stakeholders with whom we partner across the healthcare system.
Read more below. Congratulations, Ashley!”
More information here: https://www.gene.com/media/statements/ps_121223
Source: Genentech / LinkedIn